Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Clinical Nuclear Medicine|February 3, 2011
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapyEvan Y Yu, Mark Muzi, Joy A Hackenbracht, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Complexities of Next-Generation Sequencing in Solid Tumors: Case StudiesAlexandra O Sokolova, Brian H Shirts, Eric Q Konnick, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|May 22, 2002
The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical resultsKevin G Billingsley, David L Schwartz, Susan Lentz, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
VHA Practice Guideline Recommendations for Diffuse GliomasScott Kulich, Daniel Becker, Sanja Dacic, et al.
Endocrine-Related Cancer|July 1, 2017
Testicular vs adrenal sources of hydroxy-androgens in prostate cancerTianzhu Zang, Mary-Ellen Taplin, Daniel Tamae, et al.
The Oncologist|February 6, 2026
Tumor suppressor genes, treatments, and survival in US veterans with prostate cancerKrishny Karunanandaa, Eric Marshall Knoche, Robert Bruce Montgomery, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2015
External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgensEunpi Cho, Elahe A Mostaghel, Kenneth J Russell, et al.
Journal of the National Cancer Institute|July 30, 2009
MEK4 function, genistein treatment, and invasion of human prostate cancer cellsLi Xu, Yongzeng Ding, William J Catalona, et al.
Pageof 18